Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale
Lilly is reenergizing its attempt to challenge Novartis and Roche with a deal to buy Scorpion’s PI3Kα pipeline for up to $2.5 billion.
Nick Paul Taylor
Jan 13, 2025 9:55am
In a unique collab, Lilly and a16z forge new $500M venture fund
Jan 10, 2025 11:31am
Eli Lilly to pay Mediar $99M for pulmonary fibrosis prospect
Jan 10, 2025 8:35am
Lilly crafts deal with UK biotech for new ALS antibodies
Jan 9, 2025 10:55am
Lilly's oral SERD Ember counts on Verzenio to broaden its glow
Dec 11, 2024 8:15am
Lilly's lipoprotein-blocking heart drug posts midstage trial win
Nov 19, 2024 9:55am
